Crescent Capital BDC, Inc. (CCAP)
As-reported financials and recent SEC filings for Crescent Capital BDC, Inc., latest fiscal period FY2025. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.
About Crescent Capital BDC, Inc.
Crescent Capital BDC, Inc. is a specialty finance company that lends primarily to middle-market U.S. companies with annual EBITDA between $10 million and $250 million. It invests mainly in secured and unsecured debt, including first lien, unitranche first lien, second-lien, mezzanine, and subordinated debt, as well as related equity securities. The company serves private middle-market businesses, often those controlled by private equity investors, providing capital for growth, acquisitions, recapitalizations, and leveraged buyouts.
Snapshot
Fundamentals are from SEC filings. P/E and market cap are derived from recent market prices, refreshed on a rolling basis (typically within the past week).
Peer comparison
Where Crescent Capital BDC’s fundamentals sit among the 52 business development companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).
No open-market insider transactions recorded in the last 90 days. For context, about 16% of companies in the universe saw any open-market insider buying in the same window. Browse insider activity →
Percentiles describe where a figure sits among business development company peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice.
Institutional ownership
Held by 3 quant / multi-strat books among the superinvestors we track; no conviction manager currently reports a position.
| Investor | As of | Position value | Shares | Change |
|---|---|---|---|---|
| Two Sigma Investmentsquant | Q1 2026 | $3.7M | 303.6K | Added |
| D. E. Shawquant | Q1 2026 | $340,613 | 28.0K | Reduced |
| Millennium Managementquant | Q1 2026 | $134,185 | 11.0K | New |
No longer held by: Citadel Advisors (as of Q1 2026)
From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.
Income statement (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | $-98.7M | $-106.8M | $-100.3M | $-56.8M | $-44.1M |
| Net income | $34.5M | $73.6M | $83.8M | $15.5M | $83.6M |
| Diluted EPS | $1.81 | $2.40 | $2.30 | $1.93 | $1.67 |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.
Balance sheet (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash and equivalents | $5.0M | $10.1M | $7.8M | $6.4M | $10.1M |
| Current assets | — | — | — | — | — |
| Total assets | $1.62B | $1.66B | $1.63B | $1.30B | $1.32B |
| Current liabilities | — | — | — | — | — |
| Long-term debt | $873.8M | $875.8M | $844.8M | $654.5M | $631.0M |
| Total liabilities | $916.1M | $915.6M | $884.8M | $690.3M | $665.5M |
| Total equity | $706.0M | $740.6M | $742.6M | $612.5M | $652.3M |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.
Cash flow (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Operating cash flow | $74.7M | $58.9M | $92.3M | $28.0M | $-157.7M |
| Capital expenditure | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.
Quarterly trend (as reported)
| Quarter | Revenue | Revenue YoY | Net income | Diluted EPS |
|---|---|---|---|---|
| Q1 FY2026 | — | — | $-15.5M | — |
| Q4 FY2025 | — | — | $8.5M | $0.23 |
| Q3 FY2025 | — | — | $7.1M | — |
| Q2 FY2025 | — | — | $15.0M | $0.46 |
| Q1 FY2025 | — | — | $3.9M | — |
| Q4 FY2024 | — | — | $10.0M | $0.27 |
| Q3 FY2024 | — | — | $15.3M | $0.64 |
| Q2 FY2024 | — | — | $20.4M | $0.59 |
Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.
Company facts
Recent SEC filings
Largest Financials peers
Monitor CCAP
Get an alert when Crescent Capital BDC files something material, see which superinvestors own it, and ask its filings a question with cited answers.
Monitor CCAP freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.